IR@PKUHSC  > 北京大学临床肿瘤学院  > 肿瘤内科
学科主题临床医学
L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma
Yong, WB; Zhena, W; Zhang, YT; Zhu, J; Wei, Y; Zhu, DL; Li, JY
关键词L-asparaginase treatment T/NK-cell lymphoma
刊名INTERNATIONAL JOURNAL OF HEMATOLOGY
2003-08-01
78期:2页:163-167
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Hematology
研究领域[WOS]Hematology
关键词[WOS]NON-HODGKINS-LYMPHOMA ; PROGNOSTIC FACTORS ; T-CELL ; CLASSIFICATION ; EXPRESSION ; RADIATION ; CHOP
英文摘要

Nasal, nasal-type T-cell/natural killer cell (T/NK-cell) lymphoma is a rare disease, and its prognosis is poor. Between March 1992 and March 2002 we investigated a new L-asparaginase-based salvage regimen to treat the disease and improve response to treatment and 5-year overall survival rate. Eighteen patients with refractory midline nasal, nasal-type T/NK-cell lymphoma, who were resistant to a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)-like regimen, received an L-asparaginase-based salvage regimen (L-asparaginase, vincristine, and dexamethasone). Primary involved field radiation was given to the patients after chemotherapy. Ten (55.6%) of the patients achieved complete response (CR). Five patients (27.8%) achieved partial response (PR). The overall response rate (CR + PR) was 83.3%. The 5-year overall survival rate was 55.6%. Results of the preliminary clinical study indicated that the L-asparaginase-based salvage regimen significantly improved the response rate and 5-year survival rate. The findings suggested that the therapy is a promising new salvage regimen for treating refractory midline nasal, nasal-type T/NK-cell lymphoma. (C) 2003 The Japanese Society of Hematology.

语种英语
WOS记录号WOS:000184978700012
Citation statistics
Cited Times:75[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/64267
Collection北京大学临床肿瘤学院_肿瘤内科
作者单位1.Peking Univ, Beijing Canc Hosp, Sch Oncol, Dept Med Oncol, Beijing, Peoples R China
2.Peking Univ, Beijing Canc Hosp, Sch Oncol, Dept Pathol, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Yong, WB,Zhena, W,Zhang, YT,et al. L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY,2003,78(2):163-167.
APA Yong, WB.,Zhena, W.,Zhang, YT.,Zhu, J.,Wei, Y.,...&Li, JY.(2003).L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.INTERNATIONAL JOURNAL OF HEMATOLOGY,78(2),163-167.
MLA Yong, WB,et al."L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma".INTERNATIONAL JOURNAL OF HEMATOLOGY 78.2(2003):163-167.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Yong, WB]'s Articles
[Zhena, W]'s Articles
[Zhang, YT]'s Articles
百度学术
百度学术Similar articles in
[Yong, WB]'s Articles
[Zhena, W]'s Articles
[Zhang, YT]'s Articles
必应学术
必应学术Similar articles in
[Yong, WB]'s Articles
[Zhena, W]'s Articles
[Zhang, YT]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.